Moderna: buy trade in its management phase, week 13
Moderna -12.7%: the trade is still 34.36% up, with the model's coverage complete
Our view last week
Moderna stock drops 12.1% on the week, yet the buy signal, now in week 12, is still 53.91% up since entry. The trade is in its management phase and the model's coverage is complete, with all three targets reached back in week 5. In our view the pullback changes little: the residual capital stays in the trade, and the gain built so far still leaves a comfortable cushion.
This week's summary
Moderna stock falls 12.7% on the week, yet the buy signal, now in week 13, is still 34.36% up since entry. The trade is in its management phase and the model's coverage is complete: all three reference levels were hit back in week 5, and only the residual capital remains in play. Our model expects a wide move on this signal.
Disclaimer. Technical analysis and personal opinion of the author, not financial advice or a personalised recommendation. The author may hold positions in the instruments analysed. Read more ▾Close ▴
Disclaimer — The content on this page is published for educational and informational purposes and represents the author's personal opinion and technical analysis. It is not financial advice, a solicitation to invest, or personalised recommendation. Trading financial instruments involves significant risks and may result in the loss of all or part of the invested capital. Every operational decision is the sole responsibility of the user, who acknowledges acting in full autonomy and full awareness of risk. The author may hold, open or close positions in the instruments analysed, including positions opposite to the analysis, before or after publication, with no obligation to disclose them.
restricted Platinum content